An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits

PHASE4CompletedINTERVENTIONAL

Enrollment

157

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Traumatic Brain Injury With Persistent Cognitive Deficits

Interventions

DRUG

Rivastigmine